UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference
MORRISVILLE, N.C., April 01, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that the company will provide an overview of the company's business at a fireside chat at the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9, 2025, beginning at 8:45 a.m. ET.
Access to a webcast of the presentation will be available on the 'Investors' page of Liquidia's website at https://liquidia.com/investors/events-and-presentations.
An archived, recorded version of the presentation will be available on Liquidia's website for at least 30 days following the event.
About Liquidia CorporationLiquidia Corporation is a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease. The company's current focus spans the development and commercialization of products in pulmonary hypertension and other applications of its proprietary PRINT® Technology. PRINT enabled the creation of Liquidia's lead candidate, YUTREPIA™ (treprostinil) inhalation powder, an investigational drug for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company is also developing L606, an investigational sustained-release formulation of treprostinil administered twice-daily with a next-generation nebulizer, and currently markets generic Treprostinil Injection for the treatment of PAH. To learn more about Liquidia, please visit www.liquidia.com.
Contact Information
Investors:Jason AdairChief Business Officer919.328.4350jason.adair@liquidia.com
Media:Patrick WallaceDirector, Corporate Communications919.328.4383patrick.wallace@liquidia.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
Tech shares climb after strong Nvidia results despite warning over rise of Chinese rivals
Technology shares climbed on Thursday, buoyed by strong results from Nvidia, despite the AI chip company's boss issuing a warning about the rise of Chinese rivals. The Stoxx Europe tech index rose by 0.8% on Thursday following Nvidia's financial report, with the Dutch semiconductor equipment maker ASML rallying by 2.4%. In the US, futures for the tech-focused Nasdaq climbed 2%, and shares in Nvidia itself jumped 6% in pre-market trading. The boost to tech and artificial intelligence stocks came hours after Nvidia beat Wall Street forecasts, with quarterly revenues jumping 69% to $44bn (£32.6bn). The company also said it expected deals in the Middle East to start to fill a gap left by the loss of Chinese business. In April the US president, Donald Trump, said he was restricting AI chip exports to China, in effect barring Nvidia from selling its H20 AI chips to Chinese companies and blocking a major source of its revenue. Nvidia's chief executive, Jensen Huang, warned that Chinese rivals were benefiting from the void left by US firms forced to abandon the market due to US trade restrictions. 'The Chinese competitors have evolved,' Huang told Bloomberg Television. He added that Huawei, which had been blacklisted by the US government, had become 'quite formidable'. 'Like everybody else, they are doubling, quadrupling capabilities every year,' Huang said. 'And the volume is increasing substantially.' While the US government policy is meant to keep AI technologies out of the hands of Chinese actors, Huang said local companies are simply finding other options. 'You cannot underestimate the importance of the China market,' Huang said. 'This is the home of the world's largest population of AI researchers.' Nvidia said it expects to miss out on $8bn in revenue in the second quarter as a result of Trump's trade restrictions. Tech investors were also optimistic after a US trade court ruled against Trump's sweeping tariffs regime, in a move that could ultimately block the president's sweeping trade levies. But there is further uncertainty ahead, with the White House having already filed an appeal against the decision, issued by judges from the New York-based court of international trade. Meanwhile, shares in Tesla, another leader in artificial intelligence technology, rose 2.6%, after the company's chief executive, Elon Musk, confirmed that he would formally leave his role in the Trump administration. Musk has been leading the 'department of government efficiency' (Doge) since January, which ruthlessly cut state spending across a number of public departments and agencies. He said in April he would be stepping back after seeing Tesla's earnings plunge and failing to win a supreme court race in which he spent millions of dollars supporting a Republican candidate. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
43 minutes ago
- Yahoo
Former head trader of Denver-based investing company pleads guilty to insider trading
DENVER (KDVR) — A Connecticut man pleaded guilty to an insider trading charge on Friday for actions he took while employed at Denver-based firm Irving Investors. Ryan Squillante, 40, of Weston, Connecticut, was employed as the head of equity trading at Irving Investors at the time of the offense, according to the U.S. Attorney's Office for the District of Connecticut. While there, he received 'material non-public information' about some publicly traded companies. Australian hacker sentenced in May arrested by HSI Denver, faces deportation Prosecutors say that Squillante used MNPI on 15 different occasions between August 2022 and May 2023 for his own benefit, profiting about $220,912 from the transactions, according to the attorney's office. The U.S. Attorney's Office for the District of Connecticut provided an example of one of the times Squillante reportedly received MNPI about a clinical-stage biopharmaceutical company called Praxis Precision Medicines. Praxis is traded on the NASDAQ. The prosecutors said that between Feb. 27, 2023, and March 2, 2023, Squillante 'sold short' over 38,000 shares of Praxis for an average price per share of $3.04. On March 3, prosecutors say Squillante announced poor results of the company's drug trial before the market opened. Following that announcement, Squillante 'covered' the same number of shares at an average price of $1.82 per share, making a profit of about $46,421. Squillante pleaded guilty to securities fraud, which has a maximum term of imprisonment of 20 years. He's scheduled to be sentenced on Aug. 29. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
2 hours ago
- Yahoo
Quantum Computing Inc. Reports First Quarter 2025 Financial Results
HOBOKEN, N.J., May 15, 2025 /PRNewswire/ -- Quantum Computing Inc. ("QCi" or the "Company") (Nasdaq: QUBT), an innovative, integrated photonics and quantum optics technology company, today released financial results for the three-month period ended March 31, 2025. Dr. Yuping Huang, Interim Chief Executive Officer of QCi, commented, "QCi delivered solid operational and financial progress in the first quarter, strengthening our balance sheet and advancing key strategic initiatives. We completed construction during the quarter of our Quantum Photonic Chip Foundry in Tempe, Arizona, a major milestone that positions us to meet growing demand for thin film lithium niobate (TFLN) photonic chips, underscored by the announcement of a fifth purchase during the period. We're encouraged by our early traction, which is the first step in what we believe is a significant, multi-year opportunity to serve the expanding markets in datacom, telecom, and quantum-enabled applications. In parallel, we continued to deepen engagement with both government and commercial partners, reinforcing the growing interest in our quantum and photonic machines and positioning QCi to capitalize on emerging opportunities ahead." First Quarter 2025 Financial Highlights First quarter 2025 revenues totaled approximately $39,000 (33% gross margin) compared to $27,000 (41% gross margin) generated in the first quarter of 2024. Gross margin can vary at our current revenue levels. As such, the year-over-year decrease is not unexpected. First quarter 2025 operating expenses totaled $8.3 million compared to the previous year's first quarter operating expenses of $6.3 million. The year-over-year increase was primarily driven by higher employee-based expenses. The Company reported net income attributable to common stockholders of $17.0 million, or $0.13 per basic share for the first quarter of 2025, compared to a net loss attributable to common stockholders of $6.4 million or $(0.08) per basic share for the same period of the previous year. The increase in net income this quarter was primarily due to a $23.6 million non-cash gain on the mark-to-market valuation of the Company's warrant liability as a result of our merger with QPhoton in June 2022. Total assets at March 31, 2025 were $242.5 million, increasing from $153.6 million at December 31, 2024. Cash and cash equivalents at March 31, 2025 increased by $87.5 million to $166.4 million from year-end 2024. During the first quarter, the Company raised total net proceeds of $93.6 million through a private placement offering of common stock. Total liabilities at March 31, 2025 were $21.7 million, a decrease of $24.6 million compared to year-end 2024, driven primarily by the previously-mentioned non-cash changes in the fair value of the Company's warrant liability. As of March 31, 2025, the Company had shareholders' equity totaling $220.8 million. First Quarter 2025 Operational Highlights Quantum Photonic Chip Foundry Update: During the quarter, QCi completed construction of its Quantum Photonic Chip Foundry in Tempe, Arizona, achieving a key milestone in scaling its U.S.-based TFLN manufacturing services. The Company is now establishing its process design kit (PDK) and filling customer orders. To date, the Company has received five initial orders for its foundry services. Advancing Quantum Machine Adoption: On January 15, 2025, QCi announced a collaboration with Sanders Tri-Institutional Therapeutics Discovery Institute (Sanders TDI), a non-profit drug discovery institute comprising Memorial Sloan Kettering Cancer Center, The Rockefeller University, and Weill Cornell Medicine. Through this partnership, Sanders TDI will leverage cloud-based access to QCi's Dirac-3 quantum optimization machine to support computational chemistry and biomolecular modeling research. This collaboration highlights growing adoption of QCi's quantum systems in real-world biomedical applications. Board Appointment Strengthens Strategic Leadership: On March 26, 2025, QCi appointed Eric Schwartz to its Board of Directors. Mr. Schwartz brings over 20 years of experience in corporate finance, mergers and acquisitions, and corporate strategy, with a strong track record guiding companies through commercialization and manufacturing scale-up. His expertise will support QCi's growth initiatives as the Company advances its TFLN chip foundry and drives market adoption of its quantum machines. Strengthening Sales & Market Presence: The Company continued to expand its commercial and government engagement, participating in numerous trade shows and conferences during the quarter to showcase its quantum optimization and photonic chip solutions to prospective customers and partners. Advancing Strategic Partnerships with NASA: Subsequent to the quarter on April 30, 2025, QCi was awarded a subcontract valued at approximately $406,000 through Analytical Mechanics Associates (AMA) to support NASA's Langley Research Center. Under the project, QCi will use its Dirac-3 quantum computer to develop a quantum-based technique for removing sunlight noise from space-based LIDAR data, an obstacle that has historically limited NASA's ability to conduct reliable daytime Earth observation. This project builds on QCi's prior work with NASA. Expanding Commercial Adoption of Quantum Solutions: Subsequent to the quarter, QCi secured two additional customer orders, reflecting growing global demand for its quantum machines. On April 1, 2025, the Company announced the sale of a Quantum Photonic Vibrometer to the Department of Aerospace Structures and Materials at Delft University of Technology in the Netherlands, supporting advanced research in non-destructive testing and structural health monitoring. Later in the month, on April 22, 2025, QCi announced the sale of an EmuCore reservoir computing device to a major automotive manufacturer for research and development use. These orders underscore QCi's strategy to broaden awareness and adoption of its quantum solutions across both academic and industrial markets globally. Earnings Conference Call The Company will host its first quarter conference call on Thursday, May 15, 2025, at 4:30 p.m. To access the live webcast of the conference call, visit the QCi Investor Relations page at Investors may also access the webcast via the following link: To participate in the call by phone, dial (888) 506-0062 approximately five minutes prior to the scheduled start time. International callers please dial (973) 528-0011. Callers should use access code: 832763. A replay of the teleconference will be available until May 22, 2025, and may be accessed by dialing (877) 481-4010. International callers may dial (919) 882-2331. Callers should use conference ID: 52325. About Quantum Computing Inc. Quantum Computing Inc. (Nasdaq: QUBT) is an innovative, integrated photonics and quantum optics technology company that provides accessible and affordable quantum machines to the world today. QCi's products are designed to operate at room temperature and low power at an affordable cost. The Company's portfolio of core technologies and products offer unique capabilities in the areas of high-performance computing, artificial intelligence, and cybersecurity, as well as remote sensing applications. Company Contact:Rosalyn Christian/John NesbettIMS Investor Relationsinvestors@ Forward-Looking Statements This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements, generally identified by terms such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," "aim to," or variations of these or similar words, involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. Those statements include statements regarding the intent, belief or current expectations of QCi and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, including the timing of orders and revenue, and the outcome of ongoing collaborations and demonstration projects with certain U.S. government agencies, academic institutions and commercial customers, and that actual results may differ materially from those contemplated by such forward-looking statements. Except as required by federal securities law, QCi undertakes no obligation to update or revise forward-looking statements to reflect changed conditions. IMPORTANT NOTICE TO USERS (summary only, click here for full text of notice): All information is unaudited unless otherwise noted or accompanied by an audit opinion and is subject to the more comprehensive information contained in our SEC reports and filings. We do not endorse third-party information. All information speaks as of the last fiscal quarter or year for which we have filed a Form 10-K or 10-Q, or for historical information the date or period expressly indicated in or with such information. We undertake no duty to update the information. Forward-looking statements are subject to risks and uncertainties described in our Forms 10-Q and 10-K. QUANTUM COMPUTING INC. Consolidated Balance Sheets (in thousands, except par value data)March 31, December 31,2025 2024Assets Current assets: Cash and cash equivalents$ 166,429 $ 78,945 Accounts receivable, net 2027 Inventory 13118 Prepaid expenses and other current assets 660161Total current assets 167,24079,151Property and equipment, net 9,9768,212Operating lease right-of-use assets 1,4191,522Intangible assets, net 8,1968,972Goodwill 55,57355,573Other non-current assets 129129Total assets$ 242,533 $ 153,559 Liabilities and Stockholders' Equity Current liabilities: Accounts payable$ 2,022 $ 1,372 Accrued expenses 6472,134 Deferred revenue 8379 Other current liabilities 990974Total current liabilities 3,7424,559Derivative liability 16,90240,532Operating lease liabilities 1,0621,181Total liabilities 21,70646,272Stockholders' equity: Common stock, $0.0001 par value, 250,000 thousand shares authorized; 137,322 thousand and 129,012 thousand shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively 1413 Additional paid-in capital 404,313307,756 Accumulated deficit (183,500)(200,482)Total stockholders' equity 220,827107,287Total liabilities and stockholders' equity$ 242,533 $ 153,559 QUANTUM COMPUTING INC. Consolidated Statements of Operations (in thousands, except per share data)Three Months EndedMarch 31,2025 2024Total revenue$ 39 $ 27Cost of revenue 2616Gross profit 1311Operating expenses Research and development 2,9852,220Sales and marketing 672451General and administrative 4,6423,659Total operating expenses 8,2996,330Loss from operations (8,286)(6,319)Non-operating income (expense) Interest and other income 1,69638Interest expense, net (58)(155)Change in fair value of warrant liabilities 23,630-Income (loss) before income tax provision 16,982(6,436)Income tax provision --Net income (loss) 16,982(6,436) Net income (loss) attributable to common stockholders$ 16,982 $ (6,436) Earnings (loss) per share: Basic$ 0.13 $ (0.08)Diluted$ 0.11 $ (0.08)Weighted average shares used in computing net earnings (loss) per common share: Basic 135,21781,934Diluted 153,00681,934 View original content to download multimedia: SOURCE Quantum Computing Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
